In early February this year, on her YouTube channel "The Hangry Woman," Mila Clarke Buckley shared her positive experiences taking Ozempic, an antidiabetic medication taken via weekly subcutaneous injection that was first approved by the Food and Drug Administration in 2017. After two months on it, she recounted, her too-high average blood sugar level (the defining characteristic of diabetes) had steadily declined, her constant and intrusive cravings for food had gone away, and she began to lose weight consistently. But she also, like many users, experienced a week or so long bout of gastrointestinal symptoms like nausea and constipation once she moved up to a slightly higher dose, which was almost enough to make her stop taking the drug. Buckley stuck through the initial turbulence, though, and in a six-month update video, she called it a wonder drug that finally helped her lower her blood sugar—a years-long frustration that she had discussed in earlier videos. In the comments of both her videos were curious onlookers and Ozempic users who backed up her claims of newfound success in managing their diabetes and losing weight. Advertisement "After I started taking it, it was almost immediate. I dropped like eight pounds within two… Read full this story
- From crystal meth to Olympic glory: the recovery and rise of Luvo Manyonga
- These Are The Best Books Of 2019
- Chloe Madeley says she’s ‘never regretted anything so much’ as getting ‘awful’ lip fillers
- 25 Books From This Decade We Couldn't Put Down
- The Terror Queue
- The 25 Best Books Of The Decade
A So-Called Game-Changing Weight Loss Drug Is Here—What Happens Next? have 255 words, post on gizmodo.com at August 2, 2021. This is cached page on wBlogs. If you want remove this page, please contact us.